These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 17626248

  • 1. Change of expression levels of alpha1-adrenoceptor subtypes by administration of alpha1d-adrenoceptor-subtype-selective antagonist naftopidil in benign prostate hyperplasia patients.
    Kojima Y, Sasaki S, Shinoura H, Hayase M, Kubota Y, Hayashi Y, Tsujimoto G, Kohri K.
    Prostate; 2007 Sep 01; 67(12):1285-92. PubMed ID: 17626248
    [Abstract] [Full Text] [Related]

  • 2. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.
    Kojima Y, Sasaki S, Oda N, Koshimizu TA, Hayashi Y, Kiniwa M, Tsujimoto G, Kohri K.
    Prostate; 2009 Oct 01; 69(14):1521-8. PubMed ID: 19544328
    [Abstract] [Full Text] [Related]

  • 3. Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia.
    Kojima Y, Sasaki S, Kubota Y, Hayase M, Hayashi Y, Shinoura H, Tsujimoto G, Kohri K.
    J Urol; 2008 Mar 01; 179(3):1040-6. PubMed ID: 18206918
    [Abstract] [Full Text] [Related]

  • 4. Quantification of alpha1-adrenoceptor subtypes by real-time RT-PCR and correlation with age and prostate volume in benign prostatic hyperplasia patients.
    Kojima Y, Sasaki S, Shinoura H, Hayashi Y, Tsujimoto G, Kohri K.
    Prostate; 2006 May 15; 66(7):761-7. PubMed ID: 16425183
    [Abstract] [Full Text] [Related]

  • 5. Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.
    Kojima Y, Sasaki S, Kubota Y, Imura M, Oda N, Kiniwa M, Hayashi Y, Kohri K.
    J Urol; 2011 Oct 15; 186(4):1530-6. PubMed ID: 21855934
    [Abstract] [Full Text] [Related]

  • 6. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T.
    BJU Int; 2006 Apr 15; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [Abstract] [Full Text] [Related]

  • 7. Doxazosin treatment causes differential alterations of alpha 1-adrenoceptor subtypes in the rat kidney, heart and aorta.
    Yono M, Foster HE, Shin D, Takahashi W, Pouresmail M, Latifpour J.
    Life Sci; 2004 Oct 08; 75(21):2605-14. PubMed ID: 15363664
    [Abstract] [Full Text] [Related]

  • 8. Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate.
    Walden PD, Gerardi C, Lepor H.
    J Urol; 1999 Feb 08; 161(2):635-40. PubMed ID: 9915474
    [Abstract] [Full Text] [Related]

  • 9. Mechanical function and gene expression of alpha(1)-adrenoceptor subtypes in dog intravesical ureter.
    Kobayashi S, Tomiyama Y, Hoyano Y, Yamazaki Y, Kusama H, Kubota Y, Sasaki S, Kohri K.
    Urology; 2009 Aug 08; 74(2):458-62. PubMed ID: 19371927
    [Abstract] [Full Text] [Related]

  • 10. Naftopidil, a selective {alpha}1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma.
    Hori Y, Ishii K, Kanda H, Iwamoto Y, Nishikawa K, Soga N, Kise H, Arima K, Sugimura Y.
    Cancer Prev Res (Phila); 2011 Jan 08; 4(1):87-96. PubMed ID: 21205739
    [Abstract] [Full Text] [Related]

  • 11. Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trial.
    Gotoh M, Kamihira O, Kinukawa T, Ono Y, Ohshima S, Origasa H, Tokai Urological Clinical Trial Group.
    BJU Int; 2005 Sep 08; 96(4):581-6. PubMed ID: 16104914
    [Abstract] [Full Text] [Related]

  • 12. [The role of alpha1-adrenoceptor subtypes in benign prostatic hyperplasia-from bed to bench].
    Kojima Y, Hayase M, Imura M, Okada S, Kubota Y, Sasaki S, Hayashi Y, Kohri K.
    Hinyokika Kiyo; 2008 Jun 08; 54(6):457-62. PubMed ID: 18634446
    [Abstract] [Full Text] [Related]

  • 13. Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment.
    Awa Y, Suzuki H, Hamano S, Okano T, Sakurayama Y, Ohki T, Egoshi K, Ota S, Mori I, Ichikawa T.
    Int J Urol; 2008 Aug 08; 15(8):709-15. PubMed ID: 18662175
    [Abstract] [Full Text] [Related]

  • 14. Expression of alpha1 adrenoceptor subtypes mRNA in hepatic tissues of cirrhotic patients with portal hypertension.
    Zhu J, Chen L, Leng X, Du R.
    Zhonghua Wai Ke Za Zhi; 2000 May 08; 38(5):325-8. PubMed ID: 11832047
    [Abstract] [Full Text] [Related]

  • 15. Doxazosin-induced up-regulation of alpha 1A-adrenoceptor mRNA in the rat lower urinary tract.
    Yono M, Foster HE, Shin D, Takahashi W, Pouresmail M, Latifpour J.
    Can J Physiol Pharmacol; 2004 Oct 08; 82(10):872-8. PubMed ID: 15573147
    [Abstract] [Full Text] [Related]

  • 16. Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study.
    Maruyama O, Kawachi Y, Hanazawa K, Koizumi K, Yamashita R, Sugimura S, Honda S, Sugiyama Y, Saitoh T, Noto K.
    Int J Urol; 2006 Oct 08; 13(10):1280-5. PubMed ID: 17010005
    [Abstract] [Full Text] [Related]

  • 17. Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission.
    Hisasue S, Furuya R, Itoh N, Kobayashi K, Furuya S, Tsukamoto T.
    Int J Urol; 2006 Oct 08; 13(10):1311-6. PubMed ID: 17010010
    [Abstract] [Full Text] [Related]

  • 18. Examination of alpha 1 adrenoceptor subtypes in the human ureter.
    Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K.
    Int J Urol; 2007 Aug 08; 14(8):749-53. PubMed ID: 17681068
    [Abstract] [Full Text] [Related]

  • 19. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
    Nanda K, Naruganahalli KS, Gupta S, Malhotra S, Tiwari A, Hegde LG, Jain S, Sinha N, Gupta JB, Chugh A, Anand N, Ray A.
    Eur J Pharmacol; 2009 Apr 01; 607(1-3):213-9. PubMed ID: 19239913
    [Abstract] [Full Text] [Related]

  • 20. An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.
    Pulito VL, Li X, Varga SS, Mulcahy LS, Clark KS, Halbert SA, Reitz AB, Murray WV, Jolliffe LK.
    J Pharmacol Exp Ther; 2000 Jul 01; 294(1):224-9. PubMed ID: 10871316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.